Literature DB >> 35639257

Anakinra in Creutzfeldt-Jakob disease.

Giuseppe Bomboi1, Maria Laura Bernardo2, Daniele Mei3, Nicola P Falcone3, Mauro Vannicola2.   

Abstract

Entities:  

Year:  2022        PMID: 35639257     DOI: 10.1007/s13760-022-01993-2

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


× No keyword cloud information.
  5 in total

1.  The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease.

Authors:  B Van Everbroeck; E Dewulf; Ph Pals; U Lübke; J-J Martin; P Cras
Journal:  Neurobiol Aging       Date:  2002 Jan-Feb       Impact factor: 4.673

2.  Inhibition of IL-1β Signaling Normalizes NMDA-Dependent Neurotransmission and Reduces Seizure Susceptibility in a Mouse Model of Creutzfeldt-Jakob Disease.

Authors:  Ilaria Bertani; Valentina Iori; Massimo Trusel; Mattia Maroso; Claudia Foray; Susanna Mantovani; Raffaella Tonini; Annamaria Vezzani; Roberto Chiesa
Journal:  J Neurosci       Date:  2017-09-18       Impact factor: 6.167

3.  Myoclonus in Creutzfeldt-Jakob disease: polygraphic and video-electroencephalography assessment of 109 patients.

Authors:  Simona Binelli; Pamela Agazzi; Laura Canafoglia; Vidmer Scaioli; Ferruccio Panzica; Elisa Visani; Giuseppe Di Fede; Giorgio Giaccone; Alberto Bizzi; Orso Bugiani; Guiliano Avanzini; Fabrizio Tagliavini; Silvana Franceschetti
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

4.  Interleukin-1 receptor is a target for adjunctive control of diazepam-refractory status epilepticus in mice.

Authors:  Zheng-Hao Xu; Yi Wang; An-Feng Tao; Jie Yu; Xiao-Yu Wang; Yun-Yun Zu; Shi-Hong Zhang; Zhong Chen
Journal:  Neuroscience       Date:  2016-04-28       Impact factor: 3.590

5.  Anakinra treatment for refractory cerebral autoinflammatory responses.

Authors:  Yoonhyuk Jang; Woo-Jin Lee; Han Sang Lee; Kon Chu; Sang Kun Lee; Soon-Tae Lee
Journal:  Ann Clin Transl Neurol       Date:  2022-01-18       Impact factor: 4.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.